cabergoline
Selected indexed studies
- Cabergoline treatment in cats with diabetes mellitus and hypersomatotropism. (J Feline Med Surg, 2022) [PMID:35133181]
- Cabergoline in acromegaly. (Pituitary, 2017) [PMID:28025719]
- Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Pregnancy Loss: A Randomized Controlled Trial. (Obstet Gynecol, 2023) [PMID:37486652]
_Worker-drafted node — pending editorial review._
Connections
cabergoline is a side effect of
Sources
- Cabergoline treatment in cats with diabetes mellitus and hypersomatotropism. (2022) pubmed
- Cabergoline in acromegaly. (2017) pubmed
- Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Pregnancy Loss: A Randomized Controlled Trial. (2023) pubmed
- Cabergoline Use and Pregnancy Outcomes: A Systematic Review. (2025) pubmed
- Cabergoline: a review of its use in the inhibition of lactation for women living with HIV. (2019) pubmed
- Pituitary acting drugs: cabergoline and pasireotide. (2022) pubmed
- Real-world value of cabergoline in the treatment of acromegaly. (2024) pubmed
- Safety of Cabergoline for Prolactinoma in Pregnancy: A Systematic Review and Meta-Analysis. (2025) pubmed
- Approach to the Patient With Prolactinoma. (2023) pubmed
- Cabergoline for preventing ovarian hyperstimulation syndrome. (2012) pubmed